Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Bruker Corporation - Common Stock (NQ:BRKR)

56.25 +2.84 (+5.32%)
Streaming Delayed Price Updated: 2:52 PM EDT, Aug 10, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Bruker Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
News headline image
Bruker Announces Majority Investment in MIMETAS to Advance Human Physiology-Relevant Drug Discovery and Development
From Bruker Corporation
Via Business Wire
News headline image
Bruker Reports Second Quarter 2026 Financial Results
From Bruker Corporation
Via Business Wire
News headline image
Bruker Announces Date and Time of Second Quarter 2026 Earnings Release and Webcast
From Bruker Corporation
Via Business Wire
News headline image
Bruker Expands Infection Detection Portfolio with Acquisition of Metagenomic mNGS DISQVER® Platform for Pathogenic Microorganisms in Blood
From Bruker Corporation
Via Business Wire
News headline image
Bruker Showcases Expanding Microbiology & Infection Diagnostics Portfolio at ASM Microbe 2026
From Bruker Corporation
Via Business Wire
News headline image
Bruker Launches new timsMRMS Mass Spectrometry Platform for Unique Ultra-Complex Mixture Applications in the Energy Industry
From Bruker Corporation
Via Business Wire
News headline image
Bruker Announces Major Strides in 4D Proteomics Performance, Further Advances In Intact and Top-Down Functional Proteoform Analysis, and Innovations in Hybrid Qual/Quant 4D Metabolomics – all to Enable Deeper Insights into Disease Biology
From Bruker Corporation
Via Business Wire
News headline image
Champalimaud Foundation’s Neuroscience and Oncology Research Benefits from 18 Tesla Ultra-High Field MRI
From Bruker Corporation
Via Business Wire
News headline image
Bruker Reports First Quarter 2026 Financial Results
From Bruker Corporation
Via Business Wire
News headline image
Bruker Announces Date and Time of First Quarter 2026 Earnings Release and Webcast
From Bruker Corporation
Via Business Wire
News headline image
Bruker Spatial Biology Showcases High Fidelity Spatial Data and Integrated Multi-platform Workflows for Unprecedented Multiomic Insights at AACR 2026
From Bruker Corporation
Via Business Wire
News headline image
Bruker Launches MyGenius PRO® High-Throughput Sample-to-Answer Molecular Diagnostics System at ESCMID 2026
From Bruker Corporation
Via Business Wire
News headline image
Bruker Expands Industry-Leading MALDI Biotyper® and IR Biotyper® Workflows for Microbial Identification and Outbreak Management
From Bruker Corporation
Via Business Wire
News headline image
Bruker Unveils New NMR Products and Workflow Solutions at ENC 2026
From Bruker Corporation
Via Business Wire
News headline image
Bruker Invests in Photothermal AFM-IR to Advance Semiconductor Research
From Bruker Corporation
Via Business Wire
News headline image
Bruker Announces Appointment of Thierry Bernard to its Board of Directors
From Bruker Corporation
Via Business Wire
News headline image
PreOmics GmbH and Biognosys AG Prevail in U.S. Patent Challenge
From Bruker Corporation
Via Business Wire
News headline image
Bruker Accelerates the Future of Diagnostic and Prognostic Spatial Proteomics with the Launch of CellScape XR
From Bruker Corporation
Via Business Wire
News headline image
Bruker Expands Collaboration with Noetik to Advance Tissue Foundational Models for Translational and Therapeutic Applications
From Bruker Corporation
Via Business Wire
News headline image
Bruker Announces Major Advancements at AGBT to Enable Complete High-Fidelity Spatial Biology Across the Biological Spectrum
From Bruker Corporation
Via Business Wire
News headline image
Bruker Advances Functional Proteomics 2.0 with timsOmniTM Mass Spectrometry Proteoform Analysis for Deeper Insights into Disease Biology
From Bruker Corporation
Via Business Wire
News headline image
Bruker Reports Fourth Quarter and Full Year 2025 Financial Results
From Bruker Corporation
Via Business Wire
News headline image
Bruker Introduces iNTApharma™, a Label‑Free Platform for Nanoparticle Characterization in mRNA Drug and Gene Therapy Development and QC
From Bruker Corporation
Via Business Wire
News headline image
Chemspeed and SciY Announce Self‑Driving Laboratory Platform Integrating Automation, Analytics and AI Orchestration
From Bruker Corporation
Via Business Wire
News headline image
Bruker Announces Quarterly Preferred Stock Dividend
From Bruker Corporation
Via Business Wire
News headline image
Bruker Announces Date and Time of Fourth Quarter 2025 Earnings Release and Webcast
From Bruker Corporation
Via Business Wire
News headline image
Bruker Announces $500 Million in Multi-Year Orders from Two Global Healthcare Companies for Supply of High-Performance Superconductors for MRI
From Bruker Corporation
Via Business Wire
News headline image
Bruker Consolidates Ownership of TOFWERK in Expansion of Mass Spectrometry Portfolio into New Applied Markets
From Bruker Corporation
Via Business Wire
News headline image
Bruker Corporation to Present at the J.P. Morgan Healthcare Conference
From Bruker Corporation
Via Business Wire
News headline image
RI Research Instruments Announces Major Orders for Enabling Technology for the Gamma-Ray Source of the Extreme Light Infrastructure (ELI)
From Bruker Corporation
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.